Millennium Management
HRMY icon

Millennium Management’s Harmony Biosciences HRMY Stock Holding History

Millennium Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,000
Closed -$232K – 6062
2025
Q1 		$232K Buy
+7,000
New +$251K ﹤0.01% 5230
2023
Q1 		– Sell
-14,000
Closed -$771K – 6569
2022
Q4 		$771K Buy
+14,000
New +$770K ﹤0.01% 4404

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management's HRMY Position: Q1 2026 in Review

Millennium Management increased its Harmony Biosciences (HRMY) stake by 312% in Q1 2026, buying an estimated $23.7M and bringing the position to 954,359 shares worth $26.7M. The position accounts for 0.01% of the portfolio, ranked #1308.

Millennium Management first reported a position in HRMY in Q3 2020 and has held it in 22 quarters since. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Millennium Management held 954,359 shares of Harmony Biosciences worth $26.7M as of Q1 2026.
  • Millennium Management bought 722,663 Harmony Biosciences shares in Q1 2026, an estimated $23.7M.
  • Harmony Biosciences made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1308 holding.
  • Millennium Management first reported a position in Harmony Biosciences in Q3 2020 and has held it in 22 quarters since.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.